Angel deal analysis
Bookended by Covid-19 restrictions, I invested in seven angel rounds this year (2 new deals and 5 follow-ons) in comparison with 2020 comprising of eight rounds (5 new and 3 follow-ons).
Of this year’s investment rounds, three were in software, three in healthcare and one in sustainable materials. Five of these deals were led by Angels, and two by VCs. One of my portfolio companies completed a Series B, another a Series A, one exited and another became a ‘Soonicorn’.